Health Technology

The FDA has cleared a second species of carcass-eating fly for use in maggot wound therapy, expanding options for treating difficult infections. While robust clinical data remains limited, this approval reflects a growing acceptance of biological solutions for stubborn wounds where traditional antibiotics fail. The move represents a significant step in medical innovation, offering a fail-safe alternative to conventional treatments.

Johnson & Johnson CEO stated that curing certain cancers is a realistic goal for the next decade, citing progress in multiple myeloma and immunotherapy. This optimism reflects significant advancements in medical science that could drastically reduce cancer mortality rates. The industry's commitment to these goals suggests a new era of breakthrough treatments is on the horizon.

New clinical trial research suggests a gene test can identify breast cancer patients who can safely skip chemotherapy. Avoiding chemo spares patients from debilitating side effects like brain fog, nausea, and nerve damage. This innovation promises to personalize treatment and improve quality of life for survivors.